News Headlines Article

Patients enlist in fight against ALS
San Francisco Business Times

Ben Harris is taking on Lou Gehrig’s disease, one Internet message board at a time. Harris and a band of fellow patients with the fatal muscle-wasting disease are actively recruiting others into a mid-stage trial of a new drug for amyotrophic lateral sclerosis, or ALS, by Neuraltus Pharmaceuticals Inc. The movement shows the growing role that the Internet, especially social media, is playing in filling key clinical trials, especially those focused on rare diseases like ALS.